APA

Huntington M. O., Krell K. E., Armour & Liljenquist J. E. (20010712). Temporary reversal by topotecan of marked insulin resistance in a patient with myelodysplastic syndrome: case report and possible mechanism for tumor necrosis factor alpha (TNF-alpha)-induced insulin resistance. : American journal of clinical oncology.

Chicago

Huntington M O, Krell K E, Armour and Liljenquist J E. 20010712. Temporary reversal by topotecan of marked insulin resistance in a patient with myelodysplastic syndrome: case report and possible mechanism for tumor necrosis factor alpha (TNF-alpha)-induced insulin resistance. : American journal of clinical oncology.

Harvard

Huntington M. O., Krell K. E., Armour and Liljenquist J. E. (20010712). Temporary reversal by topotecan of marked insulin resistance in a patient with myelodysplastic syndrome: case report and possible mechanism for tumor necrosis factor alpha (TNF-alpha)-induced insulin resistance. : American journal of clinical oncology.

MLA

Huntington M O, Krell K E, Armour and Liljenquist J E. Temporary reversal by topotecan of marked insulin resistance in a patient with myelodysplastic syndrome: case report and possible mechanism for tumor necrosis factor alpha (TNF-alpha)-induced insulin resistance. : American journal of clinical oncology. 20010712.